TTNP: priority review PDUFA for April 30: the addiction market is huge
Millions are addicted to pain meds and illicit drugs.
TTNP has a 6 month slow release abuse proof implant.
Its ProNeura technology is also being advanced for Parkinson's and chronic pain.
TTNP will receive a $50 million milestone payment upon approval in April plus hefty future royalties.
Check it out.